Retina-on-a-chip provides powerful tool for studying eye disease

The development of a retina-on-a-chip, which combines living human cells with an artificial tissue-like system, has been described today in the open-access journal eLife. This cutting-edge tool may provide a useful alternative to existing models for studying eye disease and allow scientists to test the effects of drugs on the retina more efficiently. Many diseases that cause blindness harm the […]

Read more

Micro-computed tomography provides new insights into Paget’s disease

A MedUni Vienna study group led by Peter Pietschmann from the Institute of Pathophysiologyand Allergy Research in cooperation with the University of Vienna and the Museum of Natural History Vienna has made a detailed analysis of the microarchitecture of bones affected by the bone metabolic disease known as Paget’s disease. High-resolution micro-computed tomography techniques offer insights into the course of […]

Read more

Genetic study provides novel insights into the evolution of skin color

Skin colour is one of the most visible and variable traits among humans and scientists have always been curious about how this variation evolved. Now, a study of diverse Latin American populations led by UCL geneticists has identified new genetic variations associated with skin colour. The study, published in the journal Nature Communications, found that the variation of light skin […]

Read more

argenx Provides Detailed Data from Phase 2 Clinical Trial of Efgartigimod in Immune Thrombocytopenia and Phase 1/2 Clinical Trial of Cusatuzumab in Acute Myeloid Leukemia

Breda, the Netherlands / Ghent, Belgium – December 03, 2018 — argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer, today announced  that it will share the detailed data from its Phase 2 clinical trial of efgartigimod (ARGX-113) in immune thrombocytopenia (ITP)  and […]

Read more